Aktiesnakken — September 2010
-
line- forstås
-
NeuroSearch meddeler, at den unikke farmakologiske profil af Huntexil
(pridopidine) er publiceret i European Journal of Pharmacology -
en af de mangler man ikke gider reklamere over .....
-
-
her er lidt sensationsjounalistik af VÆRSTE skuffe
-
-
der er med god vilje omsat for 700.000kr den første time.... dvs. de Globale Banker har købt for næsten 100.000 kr i amagerbanken...
-
biop: investor præsentation i går, og ingen omsætning....
-
det var 50 mio... og så er der vel ca. 50mio fra nykredit også..... 650mio to go
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind